Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.47 |
| ▸ | BLM | P54132 | 2/20 | 0.47 |
| ▸ | PMP22 | Q01453 | 2/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.47 |
| ▸ | LMNA | P02545 | 1/20 | 0.47 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.47 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.47 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.47 |
| ▸ | TSHR | P16473 | 1/20 | 0.47 |
| ▸ | DRD1 | P21728 | 1/20 | 0.47 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.47 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.47 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.47 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.47 |
| ▸ | DRD3 | P35462 | 1/20 | 0.47 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.47 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.47 |
| ▸ | EYA2 | O00167 | 1/20 | 0.43 |
| ▸ | APP | P05067 | 1/20 | 0.43 |
| ▸ | ACE | P12821 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7762313 | 0.89 | TDP1 (0.56) | TDP1BLMPMP22KDM4ELMNA | |
| SCHEMBL20079587 | 0.89 | TDP1 (0.56) | TDP1BLMPMP22KDM4ELMNA | |
| SCHEMBL18940952 | 0.89 | TDP1 (0.56) | TDP1BLMPMP22KDM4ELMNA | |
| SCHEMBL14678812 | 0.83 | TDP1 (0.44) | TDP1BLMPMP22KDM4ELMNA | |
| SCHEMBL3342184 | 0.83 | TDP1 (0.44) | TDP1BLMPMP22KDM4ELMNA | |
| SCHEMBL21228 | 0.83 | TDP1 (0.44) | TDP1BLMPMP22KDM4ELMNA | |
| SCHEMBL21116648 | 0.83 | TDP1 (0.48) | TDP1BLMPMP22KDM4ELMNA | |
| SCHEMBL20997749 | 0.81 | TDP1 (0.47) | TDP1BLMPMP22KDM4ELMNA | |
| SCHEMBL21117029 | 0.81 | TDP1 (0.47) | TDP1BLMPMP22KDM4ELMNA | |
| Water SCHEMBL7859765 | 0.81 | TDP1 (0.42) | TDP1BLMPMP22KDM4ELMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20160022842-A1 | FORMATION AND USES OF EUROPIUM | WAYNE STATE UNIVERSITY (US) | 2016-01-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160022842-A1 | FORMATION AND USES OF EUROPIUM | LETM1, CECR2, MCU | TDP1 3336/4885BLM 3877/4885PMP22 2585/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.